EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients

Kristie Rebecca Weir iD, Clémentine Tombez, Yvonne Mattmann, Sofia C Zambrano, Eliza Ferguson, Katharina Tabea Jungo, Martina Zangger, Shana Volken, Enriqueta Vallejo-Yagüe, Renata Vidonscky Lüthold, Angela Edith Schulthess-Lisibach, Christof Bieri and 4 more

Basic & Clinical Pharmacology & Toxicology · 2025

DOI: 10.1111/bcpt.70091 ↗

At a glance

Journal article in Basic & Clinical Pharmacology & Toxicology, 2025. Written by Kristie Rebecca Weir and 15 co-authors. Institution: Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland. Major MEDLINE topics: Proton Pump Inhibitors, Deprescriptions, Inappropriate Prescribing. Cited 2 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY 4.0). Funded by: Swiss National Science Foundation, Swiss Government Excellence Scholarship, Swiss National Science Foundation Scientific Exchanges grant.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Proton Pump Inhibitors (PPIs) are widely prescribed medications globally. PPIs are often inappropriately used – for example, prescribed without a clear indication, at higher‐than‐necessary doses, or for longer durations than needed – resulting in increased risks of adverse health outcomes such as nutrient deficiencies, osteoporosis‐related fractures, and kidney disease. The effectiveness of current deprescribing interventions is inconsistent; this may relate to the misalignment with behavioural mechanisms, supporting the need for a mechanism‐driven approach that targets key behavioural determinants. We co‐designed a PPI deprescribing intervention with patients and health professionals for the Swiss primary care setting. This involved identifying behavioural determinants of PPI deprescribing from the literature at both the general practitioner (GP) and patient levels, mapping them to behaviour change techniques, selecting intervention elements, and developing contextualised intervention tools to effectively influence these determinants. The intervention tools were iteratively developed and assessed through qualitative methods with 16 patients and 18 health professionals. Participants considered the tools to be acceptable and practical for use in the Swiss primary care context.

Subjects

MeSH terms (MEDLINE)

Proton Pump InhibitorsDeprescriptionsInappropriate PrescribingHumansPrimary Health CareGeneral PractitionersSwitzerlandMaleFemaleMiddle AgedAgedPractice Patterns, Physicians'Adult

Author keywords

behavioural interventioncommunicationdeprescriptionmedicationtheoretical domains framework

Substances

Proton Pump Inhibitors

Authors and institutions

  • Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
  • Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Institute of Psychology, University of Bern, Bern, Switzerland.
  • Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
  • Center for Healthcare Delivery Sciences (C4HDS) and Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Health Economics Facility, Department of Public Health, University of Basel, Basel, Switzerland.

ORCID profiles: Kristie Rebecca Weir

Funding

  • Swiss National Science Foundation
  • Swiss Government Excellence Scholarship
  • Swiss National Science Foundation Scientific Exchanges grant
  • Emerging Leader Investigator Grant Fellowship from the Australian National Health and Medical Research Council
  • Postdoc Mobility Fellowship from the Swiss National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Cite

APA

Weir, K. R., Tombez, C., Mattmann, Y., Zambrano, S. C., Ferguson, E., Jungo, K. T., Zangger, M., Volken, S., Vallejo-Yagüe, E., Lüthold, R. V., Schulthess-Lisibach, A. E., Bieri, C., Barbier, M., Juillerat, P., Streit, S., & Inauen, J. (2025). Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70091

Vancouver

Weir KR, Tombez C, Mattmann Y, Zambrano SC, Ferguson E, Jungo KT, et al. Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70091

BibTeX
@article{Weir2025,
  author = {Weir, Kristie Rebecca and Tombez, Clémentine and Mattmann, Yvonne and Zambrano, Sofia C and Ferguson, Eliza and Jungo, Katharina Tabea and Zangger, Martina and Volken, Shana and Vallejo-Yagüe, Enriqueta and Lüthold, Renata Vidonscky and Schulthess-Lisibach, Angela Edith and Bieri, Christof and Barbier, Michaela and Juillerat, Pascal and Streit, Sven and Inauen, Jennifer},
  title = {Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  doi = {10.1111/bcpt.70091}
}
Start for free →